SARS-CoV-2 Virus−Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 Virus−Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 19, Pages 10836
Publisher
MDPI AG
Online
2021-10-09
DOI
10.3390/ijms221910836
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
- (2021) Bryan A. Johnson et al. NATURE
- Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
- (2021) Xuhua Xia Viruses-Basel
- Stabilizing the closed SARS-CoV-2 spike trimer
- (2021) Jarek Juraszek et al. Nature Communications
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2
- (2021) Annette B. Vogel et al. NATURE
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2
- (2021) Renhong Yan et al. CELL RESEARCH
- Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
- (2021) Tjede Funk et al. Eurosurveillance
- Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K
- (2021) Simone Di Giacomo et al. JOURNAL OF MEDICAL VIROLOGY
- Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
- (2021) Sandile Cele et al. NATURE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
- (2021) Nuno R. Faria et al. SCIENCE
- The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA
- (2021) Jasmine Cubuk et al. Nature Communications
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
- (2021) Matthew McCallum et al. SCIENCE
- Delta variant: What is happening with transmission, hospital admissions, and restrictions?
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
- (2021) Sarah Cherian et al. Microorganisms
- The Emerging Concern and Interest SARS-CoV-2 Variants
- (2021) Edyta Janik et al. Pathogens
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
- (2020) Yuan Huang et al. ACTA PHARMACOLOGICA SINICA
- Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
- (2020) Jiandong Huo et al. Cell Host & Microbe
- Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
- (2020) Donald J. Benton et al. NATURE
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- The Potential Intermediate Hosts for SARS-CoV-2
- (2020) Jie Zhao et al. Frontiers in Microbiology
- D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
- (2020) Drew Weissman et al. Cell Host & Microbe
- Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
- (2020) Tongqing Zhou et al. Cell Host & Microbe
- In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species
- (2020) Javier Delgado Blanco et al. PLoS Computational Biology
- SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
- (2020) Mei-Yue Wang et al. Frontiers in Cellular and Infection Microbiology
- Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM
- (2020) Cong Xu et al. Science Advances
- Bat Coronaviruses in China
- (2019) Yi Fan et al. Viruses-Basel
- SWISS-MODEL: homology modelling of protein structures and complexes
- (2018) Andrew Waterhouse et al. NUCLEIC ACIDS RESEARCH
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
- (2017) Jesper Pallesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coronavirus Diversity, Phylogeny and Interspecies Jumping
- (2009) Patrick C. Y. Woo et al. EXPERIMENTAL BIOLOGY AND MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started